(MoneyControl.com) – A subsidiary of Sun Pharmaceutical Industries has received US Food and Drugs Administration (FDA) approval for its abbreviated new drug application (ANDA) to market a generic version of Valeant International’s Cardizem CD, Diltiazem Hcl extended release capsules.
Diltiazem Hcl extended release capsules are indicated for the treatment of hypertension, for the management of chronic stable angina and angina due to coronary artery spasm, Sun Pharma said Monday.